BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 2)

Cholangiocarcinoma Foundation congratulates AstraZeneca TOPAZ-1, the first Phase III trial

By

On behalf of patients and families impacted by cholangiocarcinoma (bile duct cancer), the Cholangiocarcinoma Foundation congratulates AstraZeneca and its positive results from the TOPAZ-1 Phase III trial....

Neisseria

New antibiotics to be developed for multidrug resistant gonorrhea: Griffith University receives grant

By

Researchers from the Institute of Glycomics have been awarded more than $1,100,000 million in National Health and Medical Research Council (NHMRC) grant funding to develop new antibiotics for the treatment...

Baricitinib receives WHO nod for treating patients with COVID-19

By

NewsDesk  @infectiousdiseasenews The drug baricitinib (a type of drug known as a Janus kinase (JAK) inhibitor, also used to treat rheumatoid arthritis) is strongly recommended for patients with severe...

2nd oral antiviral for treatment of COVID-19, molnupiravir, receives FDA EUA

By

NewsDesk  @infectiousdiseasenews The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Merck’s molnupiravir for the treatment of mild-to-moderate coronavirus disease...

FDA grants emergency use for COVID-19 pill, Paxlovid

By

NewsDesk  @infectiousdiseasenews The U.S. Food and Drug Administration (FDA) has authorized the emergency use of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) for the treatment...

AstraZeneca’s Evusheld monoclonal antibodies combo for pre-exposure prophylaxis receives EUA

By

NewsDesk  @infectiousdiseasenews On Wednesday, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for AstraZeneca’s Evusheld for the pre-exposure prophylaxis of COVID-19...

Lyme disease: Abandoned antibiotic, Hygromycin A, selectively kills B. burgdorferi in mice

By

NewsDesk  @infectiousdiseasenews Lyme disease cases are becoming more frequent and widespread. Currently, it affects almost half a million people nationwide each year. Lyme disease is caused by a bacterium, Borelliella...

Artesunate Amivas (artesunate) granted approval in Europe for treatment of severe malaria

By

By NewsDesk  @bactiman63  AMIVAS Ireland Ltd., specialists in treatments for rare and neglected tropical diseases, including severe malaria, announced today the European Commission has granted approval...

CMV: FDA approves Livtencity for treating post-transplant infections

By

The U.S. Food and Drug Administration approved Livtencity (maribavir) as the first drug for treating adults and pediatric patients (12 years of age and older and weighing at least 35 kilograms) with post-transplant...

Ukraine: 4 out of 10 people purchased drugs whose effectiveness and safety have not been proven

By

By NewsDesk  @bactiman63  An analysis by the Center for Combating Corruption conclude in a new study that 4 out of 10 people purchased drugs that are ineffective and absent in modern treatment standards....